RxDoctor Payments Data

Melissa Butler, PA

Physician Assistant · Centennial, CONPI 1750423190

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.7% of the total across 629 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 58 manufacturers, the largest accounting for just 22.6% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,346in general payments, 2019–2025

Across 629 payments — averaging $19.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Neurocrine Biosciences, Inc.$958
  • Lundbeck LLC$799
  • Biogen$648
  • Lilly USA, LLC$581
  • UCB, Inc.$532
  • plus $6K from 52 others

What the payments were for

  • Speaking & faculty fees$210%
  • Food & beverage$12,313100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)162$2,788
Neurocrine Biosciences, Inc.49$958
Lundbeck LLC32$799
Biogen24$648
Lilly USA, LLC27$581
UCB, Inc.20$532
SK Life Science, Inc.18$513
Pfizer42$510
Sanofi20$488
Novartis33$416
Biohaven Pharmaceuticals, Inc.14$380
Neurelis, Inc.10$347
Argenx US, Inc.18$321
Jazz Pharmaceuticals Inc.10$239
Biohaven Pharmaceutical Holding Company Ltd.17$233
AstraZeneca10$231
Livanova USA, Inc.5$231
Supernus Pharmaceuticals, Inc.20$228
Teva Pharmaceuticals USA, Inc.13$218
Axsome Therapeutics, Inc.8$215
Amgen8$152
Genentech USA, Inc.1$110
Sunovion Pharmaceuticals Inc.6$92
Eisai Inc.4$74
Scilex Pharmaceuticals Inc.3$60
Tanabe Pharma America, Inc.3$56
MDD US Operations, LLC3$55
Impel Pharmaceuticals Inc.3$48
Octapharma USA, Inc.2$46
Acadia Pharmaceuticals Inc3$45
Johnson & Johnson2$43
E.r. Squibb & Sons, L.L.C.2$39
Sobi, Inc2$38
Upsher-smith Laboratories LLC3$37
Akcea Therapeutics, Inc.2$37
Catalyst Pharmaceuticals, Inc.2$36
Greenwich Biosciences, Inc.1$36
Life Molecular Imaging Ltd2$36
Avanir Pharmaceuticals, Inc.2$36
Boston Scientific2$34
Amneal Pharmaceuticals LLC2$33
Grifols USA, LLC2$31
Sumitomo Pharma America, Inc.2$31
Merz Pharmaceuticals, LLC1$27
Zogenix Inc.1$26
Otsuka America Pharmaceutical, Inc.1$22
Collegium Pharmaceutical, Inc.1$21
Alfasigma USA, Inc.1$21
Acorda Therapeutics, Inc1$21
Alnylam Pharmaceuticals Inc.1$18
Abbott1$18
Adamas Pharmaceuticals, Inc.1$16
Xeris Pharmaceuticals, Inc.1$15
CSL Behring1$14
Currax Pharmaceuticals LLC1$13
Almatica Pharma LLC1$13
Bristol Myers Squibb1$12
GRT US Holding, Inc.1$8

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,346 in reported general payments places this provider in the 95th percentile of 2,849 physician assistant providers in Colorado.

See all physician assistant providers in Colorado

Medicare billing

Part B allowed, 2024
$6,378
Medicare patients
44
Services billed
52

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin42$783
Pramipexole DihydrochloridePramipexole Di-Hcl12$291
Duloxetine Hcl14$289
Levetiracetam13$280
Amitriptyline Hcl28$247
Pregabalin17$246
Carbidopa-LevodopaCarbidopa/Levodopa21$244
Memantine Hcl14$158
Topiramate18$115
Primidone12$102

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Upsher-smith Laboratories LLCTopiramate$37$11518 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,849 physician assistant providers in Colorado.

Other physician assistant in Centennial

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →